Artur Martynov,Boris S. Farber,Sonya Sophya Farber
申请号：
US12931458
公开号：
US20120129787A1
申请日:
2011.02.01
申请国别(地区):
US
年份:
2012
代理人:
摘要：
This invention may be used in human and veterinary medicine for the creation of a drug that is effective perorally in the treatment of oncological illnesses.Modified oligopeptides with anticancer properties distinct in that in the capacity of peptides, a mixture (assembly) of oligopeptides are used that are products of the hydrolysis of proteins with molecules changed to the opposite charge. This quantity of modified oligopeptides is capable of slowing down the activity of the heterodimer of b-importin cells and the replication of viruses whose replication cycle depends on the function of the nucleus, as well as selectively stopping the division of cancer cells and causing their death.An assembly of modified oligopeptides based on a quasi-life, dynamic, self-organizing system that is effective in the treatment of oncological illnesses at all stages of the development of the cancer process where other drugs are ineffective. This drug has a wide spectrum of activity and a low level of toxicity it is accessible for industrial production and effective at any stage of cancer.
